| Product NDC: | 0299-3849 |
| Proprietary Name: | CLOBEX |
| Non Proprietary Name: | clobetasol propionate |
| Active Ingredient(s): | .05 g/mL & nbsp; clobetasol propionate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SPRAY |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0299-3849 |
| Labeler Name: | Galderma Laboratories, L.P. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021835 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20051027 |
| Package NDC: | 0299-3849-02 |
| Package Description: | 59 mL in 1 BOTTLE (0299-3849-02) |
| NDC Code | 0299-3849-02 |
| Proprietary Name | CLOBEX |
| Package Description | 59 mL in 1 BOTTLE (0299-3849-02) |
| Product NDC | 0299-3849 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clobetasol propionate |
| Dosage Form Name | SPRAY |
| Route Name | TOPICAL |
| Start Marketing Date | 20051027 |
| Marketing Category Name | NDA |
| Labeler Name | Galderma Laboratories, L.P. |
| Substance Name | CLOBETASOL PROPIONATE |
| Strength Number | .05 |
| Strength Unit | g/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |